Michael Quigley

4.6k total citations · 1 hit paper
50 papers, 2.4k citations indexed

About

Michael Quigley is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Michael Quigley has authored 50 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 14 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Michael Quigley's work include Immune Cell Function and Interaction (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and T-cell and B-cell Immunology (8 papers). Michael Quigley is often cited by papers focused on Immune Cell Function and Interaction (10 papers), Cancer Immunotherapy and Biomarkers (8 papers) and T-cell and B-cell Immunology (8 papers). Michael Quigley collaborates with scholars based in United States, Sweden and Germany. Michael Quigley's co-authors include Alan J. Korman, John Engelhardt, M. J. Selby, Karla A. Henning, M. S. Srinivasan, Tseng-hui Timothy Chen, Yiping Yang, Xiaopei Huang, Patricia Novy and Jennifer Martinez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Michael Quigley

48 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells

2013 670 citations M. J. Selby, John Engelhardt et al. Cancer Immunology Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Quigley United States	24	1.5k	1.2k	343	158	147	50	2.4k
Evemie Schutyser Belgium	22	1.6k 1.0×	1.4k 1.2×	661 1.9×	161 1.0×	220 1.5×	30	2.8k
Hans‐Heinrich Oberg Germany	36	2.4k 1.5×	1.2k 1.0×	751 2.2×	82 0.5×	196 1.3×	85	3.5k
Samuel Darko United States	18	1.4k 0.9×	882 0.8×	399 1.2×	80 0.5×	135 0.9×	35	2.0k
Dagmar Breitfeld Germany	5	2.7k 1.8×	1.0k 0.9×	405 1.2×	57 0.4×	191 1.3×	7	3.3k
Tatyana Chtanova Australia	21	2.0k 1.3×	518 0.4×	471 1.4×	84 0.5×	252 1.7×	36	2.8k
Magdalena Huber Germany	27	2.3k 1.5×	904 0.8×	570 1.7×	128 0.8×	234 1.6×	62	3.3k
Tomohide Yamazaki United States	16	2.7k 1.8×	1.6k 1.4×	399 1.2×	140 0.9×	190 1.3×	20	3.5k
Ken‐ichiro Seino Japan	30	2.0k 1.3×	809 0.7×	846 2.5×	158 1.0×	244 1.7×	86	3.1k
Erika Ritter United States	21	1.4k 0.9×	1.1k 0.9×	722 2.1×	190 1.2×	147 1.0×	38	2.1k
Julie Harriague France	13	1.2k 0.8×	941 0.8×	524 1.5×	73 0.5×	200 1.4×	15	2.1k

Countries citing papers authored by Michael Quigley

Since Specialization

Citations

This map shows the geographic impact of Michael Quigley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Quigley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Quigley more than expected).

Fields of papers citing papers by Michael Quigley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Quigley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Quigley. The network helps show where Michael Quigley may publish in the future.

Co-authorship network of co-authors of Michael Quigley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Quigley. A scholar is included among the top collaborators of Michael Quigley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Quigley. Michael Quigley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Davra, Viralkumar, Sushil Kumar, Ke Geng, et al.. (2020). Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity. Cancer Research. 81(3). 698–712. 61 indexed citations

Case, Jamie, Sunil M. Kurian, Samantha R. Spierling Bagsic, et al.. (2020). Safety and Efficacy of a Steroid Avoidance Immunosuppression Regimen in Renal Transplant Patients With De Novo or Preformed Donor-Specific Antibodies: A Single-Center Study. Transplantation Proceedings. 53(3). 950–961. 1 indexed citations

Mina, Michael J., et al.. (2020). Analyzing Conflicting Results in Rapid Point-of-Care COVID-19 Testing. Digital Access to Scholarship at Harvard (DASH) (Harvard University). 3 indexed citations

Caetano, Mauricio S., Ahmed Younes, Hampartsoum B. Barsoumian, et al.. (2019). Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses. Clinical Cancer Research. 25(24). 7576–7584. 54 indexed citations

Wiehagen, Karla R., Natasha Girgis, Douglas H. Yamada, et al.. (2017). Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity. Cancer Immunology Research. 5(12). 1109–1121. 135 indexed citations

Selby, Mark, John Engelhardt, Robert J. Johnston, et al.. (2016). Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology. PLoS ONE. 11(9). e0161779–e0161779. 175 indexed citations

Barnhart, Bryan C. & Michael Quigley. (2016). Role of Fc–FcγR interactions in the antitumor activity of therapeutic antibodies. Immunology and Cell Biology. 95(4). 340–346. 28 indexed citations

Selby, M. J., John Engelhardt, Michael Quigley, et al.. (2013). Anti-CTLA-4 Antibodies of IgG2a Isotype Enhance Antitumor Activity through Reduction of Intratumoral Regulatory T Cells. Cancer Immunology Research. 1(1). 32–42. 670 indexed citations breakdown →

Henrickson, Sarah E., Mario Perro, Scott Loughhead, et al.. (2013). Antigen Availability Determines CD8+ T Cell-Dendritic Cell Interaction Kinetics and Memory Fate Decisions. Immunity. 39(3). 496–507. 115 indexed citations

10.

Norde, Wieger J., Frans Maas, Willemijn Hobo, et al.. (2011). PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation. Cancer Research. 71(15). 5111–5122. 126 indexed citations

11.

Quigley, Michael, Florencia Pereyra, Björn Nilsson, et al.. (2009). Integrative Genomic Analysis of HIV-Specific CD8+ T Cells Reveals That PD-1 Inhibits T Cell Function by Upregulating the AP-1 Transcription Factor BATF.. Blood. 114(22). 916–916. 1 indexed citations

12.

Novy, Patricia, Michael Quigley, Xiaopei Huang, & Yiping Yang. (2007). CD4 T Cells Are Required for CD8 T Cell Survival during Both Primary and Memory Recall Responses. The Journal of Immunology. 179(12). 8243–8251. 110 indexed citations

13.

Quigley, Michael, Xiaopei Huang, & Yiping Yang. (2007). Extent of Stimulation Controls the Formation of Memory CD8 T Cells. The Journal of Immunology. 179(9). 5768–5777. 17 indexed citations

14.

Gable, Preston, et al.. (2007). Primitive neuroectodermal tumor of the uterus. Gynecologic Oncology. 106(2). 419–422. 28 indexed citations

15.

Quigley, Michael, et al.. (2007). Stubby elliptocytes are an invariable feature of leukoerythroblastosis. Blood. 109(6). 2666–2666.

16.

Puckett, Michael L., et al.. (2004). Necrotizing Fasciitis. Radiographics. 24(5). 1472–1476. 62 indexed citations

17.

Quigley, Michael, Kelly Bethel, Robert W. Sharpe, & Alan Saven. (2003). CD52 expression in hairy cell leukemia. American Journal of Hematology. 74(4). 227–230. 35 indexed citations

18.

Quigley, Michael, et al.. (2001). Neutropenic enterocolitis: A rare presenting complication of acute leukemia. American Journal of Hematology. 66(3). 213–219. 11 indexed citations

19.

Quigley, Michael, et al.. (2000). Palisaded angioleiomyoma. Journal of Cutaneous Pathology. 27(10). 526–528. 5 indexed citations

20.

Mellon, DeForest & Michael Quigley. (1988). Disruption of muscle reorganization by lesions of the peripheral nerve in transforming claws of snapping shrimps. Journal of Neurobiology. 19(6). 532–551. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact